Drug – bio-affecting and body treating compositions – Nonspecific immunoeffector – per se ; or nonspecific...
Reexamination Certificate
2005-03-08
2005-03-08
Parkin, Jeffrey S. (Department: 1648)
Drug, bio-affecting and body treating compositions
Nonspecific immunoeffector, per se ; or nonspecific...
C530S370000, C424S231100
Reexamination Certificate
active
06863896
ABSTRACT:
The invention provides a method of increasing an immune response in a mammal. The method involves administering to the mammal an admixture comprising an immunogen and a plant lectin. The plant lectin acts as an adjuvant to increase an immune response against the immunogen. The method is especially well-suited for mucosal administration to humans and other mammals.
REFERENCES:
patent: 4414201 (1983-11-01), Shionoya et al.
patent: 4470967 (1984-09-01), Gough et al.
patent: 5445818 (1995-08-01), Hodges et al.
patent: 5603960 (1997-02-01), O'Hagan et al.
patent: 5629011 (1997-05-01), Illum
patent: 5744155 (1998-04-01), Friedman et al.
patent: 5800832 (1998-09-01), Tapolsky et al.
patent: 5804212 (1998-09-01), Illum
patent: 5814329 (1998-09-01), Shah
patent: 5876761 (1999-03-01), Bodmer et al.
patent: 5955097 (1999-09-01), Tapolsky et al.
patent: 5962428 (1999-10-01), Carrano et al.
patent: 42 21 836 (1994-01-01), None
patent: 156 633 (1985-10-01), None
patent: 8606635 (1986-11-01), None
patent: 9217167 (1992-10-01), None
Lavelle et al., “Mistletoe lectins enhance immune responses to intranasally co-administered herpes simplex virus glycoprotein D2,”Immunology 107, 268-74, 2002.
E.C.Lavelle, et al., “Mucosal Immunogenicity of Plant Lectins in Mice”, Immunology, 2000, vol. 99, pp. 30-37.
Paul J. Giannasca, et al., “Targeted Delivery of Antigen to Hamster Nasal Lymphoid Tissue with M-cell-Directed Lectins”, Infection and Immunity, Oct. 1997, pp. 4288-4298.
Neil A. Williams, et al., “Immune Modulation by the Cholera-Like Enterotoxins: From Adjuvant to Therapeutic”, Immunology Today, Feb. 1999, vol. 20, No. 2, pp. 95-101.
Wim Van den Broeck, et al., “Receptor-Dependent Immune Responses in Pigs after Oral Immunization with F4 Fimbriae”, Infection and Immunity, Feb. 1999, pp. 520-526.
H. J. de Aizpurua, et al., “Oral Vaccination: Identification of Classes of Proteins that Provoke an Immune Response upon Oral Feeding”, J. Exp. Med., Feb. 1998, vol. 167, pp. 440-451.
Naoto Shibuya, et al., “The Elderberry (Sambucus nigraL.) Bark Lectin Recognizes the Neu5Ac(α2-6)Gal/GalNAc Sequence”, The Journal of Biological Chemistry, Feb. 5, 1987, vol. 262, No. 4, pp, 1596-1601.
Tomás Girbés, et al., “Isolation and Partial Characterization of Nigrin B, a Non-toxic Novel Type 2 Ribosome-Inactivating Protein from the Bark ofSambucus nigraL.”, Plant Molecular Biology, 1993, vol. 22, pp, 1181-1186.
Lavelle et al., “Mucosal Immunologenicity and Adjuvanticity of Plant Lectins”Scandinavian Journal of Immunology 52(4) :422, Oct., 2000.
O'Hagan et al., “Intranasal Immunization with Recombinant gD2 Reduces Disease Severity and Mortality Following Genital Challenge with Herpes Simplex Virus Type 2 in Guinea Pigs”Vaccine 17:2229-2236, 1999.
Stein et al., “Induction of Anti-Mistletoe Lectin Antibodies in Relation to Different Mistletoe Extracts”Anti-Cancer Drugs 8(Suppl 1):S57-S59.
Lavelle et al., “The Identification of Plant Lectins with Mucosal Adjuvant Activity”Immunology 102:77-86, 2001.
Lavelle Edward C.
O'Hagan Derek
Blackburn Robert P.
Chiron Corporation
Hale Rebecca M.
Hemmendinger Lisa M.
Parkin Jeffrey S.
LandOfFree
Plant lectins as mucosal adjuvants does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Plant lectins as mucosal adjuvants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Plant lectins as mucosal adjuvants will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3457474